Contains fulltext : 172538.pdf (publisher's version ) (Open Access)OBJECTIVES: Early testing for HIV and entry into care are crucial to optimise treatment outcomes of HIV-infected patients and to prevent spread of HIV. We examined risk factors for presentation with late or advanced disease in HIV-infected patients in the Netherlands. METHODS: HIV-infected patients registered in care between January 1996 and June 2014 were selected from the ATHENA national observational HIV cohort. Risk factors for late presentation and advanced disease were analysed by multivariable logistic regression. Furthermore, geographical differences and time trends were examined. RESULTS: Of 20 965 patients, 53% presented with late-stage HIV infect...
International audienceObjective: The objective of this study was to identify the factors associated ...
QUESTIONS UNDER STUDY:We sought to identify reasons for late human immunodeficiency virus (HIV) test...
<div><p>Objectives</p><p>To estimate HIV prevalence, the number of people living with HIV/AIDS (PLWH...
Objectives: Early testing for HIV and entry into care are crucial to optimise treatment outcomes of ...
OBJECTIVES: Early testing for HIV and entry into care are crucial to optimise treatment outcomes of ...
International audienceBACKGROUND: Our objective was to determine the frequency and determinants of p...
Objectives: In Europe, 15-38% of individuals with HIV infection are diagnosed late in the course of ...
Background: It is estimated that over half of newly diagnosed HIV infections in Europe present late....
Background:Few studies have monitored late presentation (LP) of HIV infection over the European cont...
Introduction: It is estimated that over half of newly diagnosed HIV infections in Europe present lat...
BACKGROUND: Antiretroviral therapy reduces mortality and morbidity in HIVinfected individuals, most ...
Introduction: Late HIV diagnosis is common and associated with an increased risk of clinical progres...
ObjectivesWith the purpose of reducing the well-known negative impact of late presentation (LP) on p...
QUESTIONS UNDER STUDY We sought to identify reasons for late human immunodeficiency virus (HIV) t...
Few studies have monitored late presentation (LP) of HIV infection over the European continent, incl...
International audienceObjective: The objective of this study was to identify the factors associated ...
QUESTIONS UNDER STUDY:We sought to identify reasons for late human immunodeficiency virus (HIV) test...
<div><p>Objectives</p><p>To estimate HIV prevalence, the number of people living with HIV/AIDS (PLWH...
Objectives: Early testing for HIV and entry into care are crucial to optimise treatment outcomes of ...
OBJECTIVES: Early testing for HIV and entry into care are crucial to optimise treatment outcomes of ...
International audienceBACKGROUND: Our objective was to determine the frequency and determinants of p...
Objectives: In Europe, 15-38% of individuals with HIV infection are diagnosed late in the course of ...
Background: It is estimated that over half of newly diagnosed HIV infections in Europe present late....
Background:Few studies have monitored late presentation (LP) of HIV infection over the European cont...
Introduction: It is estimated that over half of newly diagnosed HIV infections in Europe present lat...
BACKGROUND: Antiretroviral therapy reduces mortality and morbidity in HIVinfected individuals, most ...
Introduction: Late HIV diagnosis is common and associated with an increased risk of clinical progres...
ObjectivesWith the purpose of reducing the well-known negative impact of late presentation (LP) on p...
QUESTIONS UNDER STUDY We sought to identify reasons for late human immunodeficiency virus (HIV) t...
Few studies have monitored late presentation (LP) of HIV infection over the European continent, incl...
International audienceObjective: The objective of this study was to identify the factors associated ...
QUESTIONS UNDER STUDY:We sought to identify reasons for late human immunodeficiency virus (HIV) test...
<div><p>Objectives</p><p>To estimate HIV prevalence, the number of people living with HIV/AIDS (PLWH...